NCT04985604 2025-10-02Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid TumorsDay One Biopharmaceuticals, Inc.Phase 2 Terminated23 enrolled 15 charts
NCT01502410 2018-06-26Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid CancerNational Cancer Institute (NCI)Phase 2 Completed20 enrolled 14 charts